Anavex Life Sciences (AVXL) Long-Term Debt Repayments (2014)
Anavex Life Sciences (AVXL) reported Long-Term Debt Repayments of $34,759 for FY2016 (year ended Sep 30, 2016), down 60.6% from $88,144 in FY2015.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Long-Term Debt Repayments (2014) Analysis & Trends
- According to Business Quant data, Long-Term Debt Repayments came in at $88,144 in FY2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 1.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Anavex Life Sciences | 126.53 Mn | -353.54 Mn | - | - |
API Access
Anavex Life Sciences Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();